Sculptor Capital’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Sculptor Capital’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-185,650	Closed	-$15.6K	–	583
2023 Q1	$15.6K	Sell	185,650 -850	-0.5%	-$46	﹤0.01%	431
2022 Q4	$1.63K	Sell	186,500 -1,000	-0.5%	-$49	﹤0.01%	778
2022 Q3	$24K	Hold	187,500	–	–	﹤0.01%	855
2022 Q2	$20K	Hold	187,500	–	–	﹤0.01%	1027
2022 Q1	$61K	Buy	187,500 +99,999	+114%	+$40.5K	﹤0.01%	1050
2021 Q4	$48K	Buy	+87,501	New	+$44.9K	﹤0.01%	1080

Sculptor Capital's LVACW Position: Q2 2023 in Review

Sculptor Capital sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 185,650 shares — an estimated $15.6K sold.

Sculptor Capital first reported a position in LVACW in Q4 2021 and held it in 6 quarters. The position peaked at $61K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Sculptor Capital reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Sculptor Capital sold 185,650 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $15.6K.
Sculptor Capital first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 6 quarters.
Sculptor Capital's LAVA Medtech Acquisition Corp. Warrants position peaked at $61K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.